Association of Cognitive Impairment With Treatment and Outcomes in Older Myocardial Infarction Patients: A Report From the NCDR Chest Pain–MI Registry
Akshay Bagai(St. Michael's Hospital), Karen P. Alexander(Clinical Research Institute), John A. Dodson, Kirk N. Garratt(Christiana Care Health System), Martha Gulati(Cedars-Sinai Medical Center), David D. McManus(University of Massachusetts Chan Medical School), Matthew T. Roe(Clinical Research Institute), Matthew J. Maurer(Mayo Clinic in Arizona), Anita Y. Chen(University of Rochester Medicine), Jacob A. Udell(University Health Network), Judith S. Hochman(New York University), Jonathan Enriquez(Saint Luke's Hospital), Abhinav Goyal(Emory University), Timothy D. Henry(Christ Hospital)
Cited by 36
Related Papers
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k